APREMILAST and VOMITING

Overview

VOMITING is the #10 most commonly reported adverse reaction for APREMILAST, manufactured by Amgen, Inc. There are 6,346 FDA adverse event reports linking APREMILAST to VOMITING. This represents approximately 1.7% of all 370,200 adverse event reports for this drug.

Patients taking APREMILAST who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

VOMITING is a less commonly reported adverse event for APREMILAST, but still significant enough to appear in the safety profile.

Other Side Effects of APREMILAST

In addition to vomiting, the following adverse reactions have been reported for APREMILAST:

• DIARRHOEA — 24,315 reports
• NAUSEA — 21,927 reports
• PSORIASIS — 20,247 reports
• HEADACHE — 17,679 reports
• DRUG INEFFECTIVE — 15,315 reports
• ABDOMINAL DISCOMFORT — 8,065 reports
• PSORIATIC ARTHROPATHY — 7,852 reports
• PAIN — 6,595 reports
• RASH — 6,479 reports
• ARTHRALGIA — 6,226 reports

Other Drugs Associated with VOMITING

The following drugs have also been linked to vomiting in FDA adverse event reports:

Does APREMILAST cause VOMITING?

VOMITING has been reported as an adverse event in 6,346 FDA reports for APREMILAST. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is VOMITING with APREMILAST?

VOMITING accounts for approximately 1.7% of all adverse event reports for APREMILAST, making it a notable side effect.

What should I do if I experience VOMITING while taking APREMILAST?

If you experience vomiting while taking APREMILAST, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages